NEW YORK (GenomeWeb News) — A US court has awarded Invitrogen $16.2 million in damages in a patent-infringement case against Stratagene, tripling an earlier jury award, Stratagene disclosed today.
 
Stratagene said it would appeal the award and challenge the validity of Invitrogen’s patent that is at the center of the suit.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.